https://www.selleckchem.com/products/ho-3867.html
10 ± 1 p = 0.028, r = 0.58). Total MoCA score was significantly lower in COVID-19 patients than in controls (20 ± 5 vs. 26 ± 3, p = 0.042, r = 0.54). Cognitive performance indicated by MoCA was associated with number of correctly identified odors in COVID-19 patients and controls (COVID-19 p = 0.018, 95% CI = 9-19; controls p = 0.18, r = 0.63, 95% CI = 13-18.5 r = 0.64). OD is associated with cognitive impairment in controls and mild COVID-19. OD may represent a potentially useful clinical biomarker for subtle and even subclinical neuro
Like
Comment
Share
